Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Asker Healthcare Group AB ( (SE:ASKER) ) has issued an announcement.
Asker Healthcare Group will release its interim report for the first quarter of 2026 on 6 May and will host a webcast presentation the same day for investors, analysts and media. The online event, led by CEO Johan Falk and CFO Thomas Moss, will include a presentation of the results and a Q&A session, with materials and a replay made available on the company’s website, underscoring Asker’s emphasis on transparent communication with the capital markets.
The webcast offers stakeholders an opportunity to gauge Asker’s financial performance and strategic progress early in the year. By facilitating broad digital access and on-demand viewing, the group aims to maintain high engagement with its investor base, which may support confidence in its ongoing expansion across European healthcare markets.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK120.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare group that partners with caregivers and patients by providing medical products and solutions. The company builds and acquires leading local healthcare distributors to improve patient outcomes, lower total care costs and promote a fair, sustainable value chain, and today operates with more than 4,500 employees in 19 countries, generating SEK 17 billion in revenue.
Average Trading Volume: 544,318
Technical Sentiment Signal: Buy
Current Market Cap: SEK30.43B
Find detailed analytics on ASKER stock on TipRanks’ Stock Analysis page.